Cargando…
Therapeutic targets for bone metastases in breast cancer
Breast cancer is prone to metastasize to bone. Once metastatic cells are in the bone marrow, they do not, on their own, destroy bone. Instead, they alter the functions of bone-resorbing (osteoclasts) and bone-forming cells (osteoblasts), resulting in skeletal complications that cause pathological fr...
Autor principal: | Clézardin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219181/ https://www.ncbi.nlm.nih.gov/pubmed/21586099 http://dx.doi.org/10.1186/bcr2835 |
Ejemplares similares
-
The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases
por: Das, Souvik, et al.
Publicado: (2020) -
Fracture Risk Evaluation of Bone Metastases: A Burning Issue
por: Confavreux, Cyrille B., et al.
Publicado: (2021) -
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives
por: Beuzeboc, Philippe, et al.
Publicado: (2014) -
Increased Dickkopf-1 expression in breast cancer bone metastases
por: Voorzanger-Rousselot, N, et al.
Publicado: (2007) -
The role of osteoclasts in breast cancer bone metastasis
por: Le Pape, François, et al.
Publicado: (2016)